Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBAUMEVIEILLE, Marie
dc.contributor.authorPERRI-PLANDE, J.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMIREMONT-SALAME, Marie Ghada
ORCID: 0000-0002-6468-8903
IDREF: 153165766
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDAVELUY, Amelie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHARAMBURU, Françoise
IDREF: 59522674
dc.date.accessioned2020-05-11T09:42:19Z
dc.date.available2020-05-11T09:42:19Z
dc.date.issued2019
dc.identifier.issn0040-5957 (Print) 0040-5957 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/7512
dc.description.abstractEnAddictovigilance in the French Public Health Code, in the section related to poisonous substances, refers to a monitoring system developed since 1990: control of psychoactive substances and products, with medicinal use or not, was completed by a specific system focused on evaluation and information on pharmacodependance in 1999. The French medicines agency (Agence du medicament) created in 1993 was involved in this monitoring system; pharmacodependance evaluation was added by law to the missions of the agencies that followed: the Agence francaise de securite sanitaire des produits de sante missions (AFSSAPS, 1998) and the Agence nationale de securite du medicament et des produits de sante (ANSM, 2011). "Addictovigilance" first appears in French Law in 2017 whereas it was used by pharmacodependance centers and AFSSAPS since 2007. Legal definition of addictovigilance in the French Public Health Code testified to public authorities action against addictive behavior whatever products status, legal or not. The visibility of addictovigilance is growing on the Internet as well (ANSM website, web portal for reporting adverse health events).
dc.language.isoFRen_US
dc.subject.enPharmacoEpi-Drugs
dc.titleDu médicament psychoactif à l'addictovigilance dans le Code de la sante publique en France (1990-2017)
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2018.07.007en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30193805en_US
bordeaux.journalThérapieen_US
bordeaux.page375-382en_US
bordeaux.volume74en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03212354
hal.version1
hal.date.transferred2021-04-29T13:11:57Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=Du%20m%C3%A9dicament%20psychoactif%20%C3%A0%20l'addictovigilance%20dans%20le%20Code%20de%20la%20sante%20publique%20en%20France%20(1990-2017)&rft.atitle=Du%20m%C3%A9dicament%20psychoactif%20%C3%A0%20l'addictovigilance%20dans%20le%20Code%20de%20la%20sante%20publique%20en%20France%20(1990-2017)&rft.jtitle=Th%C3%A9rapie&rft.date=2019&rft.volume=74&rft.issue=3&rft.spage=375-382&rft.epage=375-382&rft.eissn=0040-5957%20(Print)%200040-5957%20(Linking)&rft.issn=0040-5957%20(Print)%200040-5957%20(Linking)&rft.au=BAUMEVIEILLE,%20Marie&PERRI-PLANDE,%20J.&MIREMONT-SALAME,%20Marie%20Ghada&DAVELUY,%20Amelie&HARAMBURU,%20Fran%C3%A7oise&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée